Viking Therapeutics, Inc. (VKTX) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	10.7	10.7	9.1	7.1	5.3	4.8	5.0	1.2
General and administrative	10.7	10.7	9.1	7.1	5.3	4.8	5.0	1.2
Research and development	45.0	31.9	23.6	19.0	13.7	9.0	7.0	22.2
EBIT [+]	-55.7	-42.7	-32.7	-26.2	-19.1	-13.8	-12.0	-23.5
EBIT growth	30.5%	30.5%	24.9%	37.2%	37.7%	15.4%	-48.9%
Interest income, net [+]	0.7	3.2	7.1	3.2	0.0	0.0	-0.1	-0.1
Interest expense						0.0	0.1	0.1
Interest income	0.7	3.2	7.1	3.2	0.0
Other income (expense), net [+]	0.0	-0.1	-0.1	0.9	-1.5	-0.9	-11.3	1.7
Amortization of debt discount premium				-0.4	-1.3	-1.8	-0.9	-0.6
Gain (loss) on investments		0.0	0.0
Gain (loss) on foreign currency transactions	0.0
Other	0.7	3.2	6.9	4.1	-1.5	-2.7	-11.4	1.6
Pre-tax income	-55.0	-39.5	-25.8	-22.1	-20.6	-14.7	-23.4	-21.9
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate		0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-55.0	-39.5	-25.8	-22.1	-20.6	-14.7	-23.4	-21.9

Basic EPS [+]	($0.71)	($0.54)	($0.36)	($0.38)	($0.79)	($0.90)	($3.68)	($5.23)
Growth	30.9%	51.9%	-6.5%	-51.6%	-12.5%	-75.4%	-29.5%
Diluted EPS [+]	($0.71)	($0.54)	($0.36)	($0.38)	($0.79)	($0.90)	($3.68)	($5.23)
Growth	30.9%	51.9%	-6.5%	-51.6%	-12.5%	-75.4%	-29.5%

Shares outstanding (basic) [+]	77.2	72.6	72.0	57.6	26.0	16.3	6.4	4.2
Growth	6.3%	0.9%	25.0%	121.6%	59.6%	156.1%	51.8%
Shares outstanding (diluted) [+]	77.2	72.6	72.0	57.6	26.0	16.3	6.4	4.2
Growth	6.3%	0.9%	25.0%	121.6%	59.6%	156.1%	51.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.